Global Angiography Equipment Market Therapeutics, Global Overview and Forecast to 2023

Market Highlights:

Angiography is an insignificantly intrusive procedure that is utilized to see the veins in the body. As of now, mechanical headways in interventional radiology have prompted the advancement of OCT-angiography, MRI-angiography, and computerized level board gadgets, which are required to drive the market development during the examination time frame.

The global Angiography Equipment Market Values is estimated to pick up unmistakable quality over the estimate time frame from 2018 to 2023. It is evaluated that the global angiography equipment market is required to enroll a CAGR of 5.2% during the conjecture time from 2018 to 2023.

Get a Free Sample @

The rising pervasiveness of cardiovascular ailments, expanding instances of angiography strategies, developing geriatric populace, and advantages of the system in early determination and treatment are significant drivers pushing the market development. For example, according to the European Union (EU) measurements, in 2015, transluminal coronary angioplasties were the most noteworthy performed methods in Germany with a normal of multiple times per 100,000 occupants. Moreover, the developing interest for Interventional Angiography Systems in negligibly intrusive medical procedures, rising medicinal services consumption, and innovative headways are supporting the market development. Nonetheless, the confinements in repayment for angiographic medical procedures and the danger of radiation presentation are significant limitations in the growth of the market.

Competitive Analysis:

Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers, Canon Corporation, (U.S.), Cordis, Boston Scientific Corporation, Shimadzu Corporation, Medtronic, B. Braun Melsungen, Angiodynamics, and Abbott Laboratories.


·         The Global Angiography Equipment Market is segmented on the basis ofthe product, technology, procedure, indication, application, and end-user.

·         Based onthe product, the market is segmented as angiography equipment solutions. The angiography equipment solutions are further segmented into angiography catheters, angiography systems, Vascular Closure Devices (VCDs), angiography contrast media, angiography balloons, angiography accessories, and angiography guidewires.

·         The global angiography equipment market based on technology is segmented as X-ray angiography, CT angiography, MR angiography, and other angiography technologies. Of these, X-ray angiography segment is further segmented into flat-panel detectors and image intensifiers.

·         The global angiography equipment market based onthe procedure is further segmented into endovascular angiography, on-angiography, coronary angiography, neuro-angiography, and other angiography procedures.

·         The global angiography equipment market based on indication is segmented into valvular heart disease, coronary artery disease,congestive heart failure, congenital heart disease, and other indications.

·         On the basis of application, the market is segmented into diagnostics and therapeutics.

·         Based on end-user, the market is segmented as hospitals and clinics, diagnostic and imaging centers, and research institutes.

Regional Analysis:

Regionally, the angiography equipment market is segmented intotheAmericas, Asia-Pacific, Europe, and Middle East & Africa. Of these, Europe commands the global angiography equipment market attributable to a well-created framework, expanding predominance of cardiovascular issue, and mechanical progressions. Also, the expanding number of angiography strategies and expanding inclination to negligibly intrusive gadgets add to the development of the market. Moreover, in 2015, according to the European Cardiovascular Diseases Statistics, 11.3 million new instances of cardiovascular infections were enrolled in Europe and 6.1 million new cases in the European Union.

Industry News:

October 2019, Shimadzu Medical Systems USA has announced that its newest digital angiography family has received a Class III Medical Device license from Health Canada.

In 2019, a new angiography room with a state-of-the-art device for stroke treatment has received investment from the European Union (EU). The organization has invested around USD 2,42,61,380.00 in five devices.